News Breaking 麻豆传媒 Channel: Zika Virus

Some Viruses 'Freeze' Their RNA to Replicate, UNC Study Says

University of North Carolina School of Medicine — Wed, 12 Feb 2025 19:45:32 EST

Researchers at the UNC School of Medicine have discovered that RNA in Zika virus can freeze itself in time to further its spread in the body, revolutionizing how researchers study disease-causing viruses.

Prenatal Zika infection has long-term immune consequences in children, even without microcephaly

Cleveland Clinic — Thu, 18 Jul 2024 13:05:05 EST

A Cleveland Clinic-led study published in eBioMedicine reveals that maternal Zika virus infections can reprogram fetal immune development, leading to long-term consequences in children's immunity.

Cases of chikungunya and zika fall in Brazil, but most risk clusters exhibit an upward trend

FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO — Thu, 18 Jan 2024 08:05:46 EST

Analysis of occurrence and co-occurrence patterns shows the highest-risk clusters of chikungunya and zika in Brazil spreading from the Northeast to the Center-West and coastal areas of Sao Paulo state and Rio de Janeiro state in the Southeast between 2018 and 2021, and increasing again in the Northeast between 2019 and 2021.

Study reveals Zika's shape-shifting machinery--and a possible vulnerability

Sanford Burnham Prebys — Fri, 08 Dec 2023 17:05:45 EST

Viruses have limited genetic material--and few proteins--so all the pieces must work extra hard. Zika is a great example; the virus only produces 10 proteins.

Prior dengue infection may make Zika virus outcomes worse

Texas Biomedical Research Institute — Tue, 20 Jun 2023 11:05:37 EST

Researchers in New York and Texas have identified that female marmosets are more likely to transmit the Zika virus during pregnancy if they have been previously infected by a different virus, dengue.

LJI-led team wins top Nucleate honors for virus vaccine development proposal

La Jolla Institute for Immunology — Thu, 25 May 2023 15:05:51 EST

A San Diego team, led by scientists at La Jolla Institute for Immunology (LJI), has won the top prizes in the Nucleate Activator competition. Out of 1,000 initial competitors, the LJI team advanced to the final four teams and swept all the prizes they entered for. Their winning research proposal outlines how scientists could stop dengue virus and Zika virus by developing sophisticated vaccines that activate both B cells and T cells.

TRANSCRIPT AND VIDEO AVAILABLE Live Event for April 21: Sleeping pill reduces levels of Alzheimer's proteins

News — Fri, 21 Apr 2023 15:10:43 EST

Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer's disease.

The mosquitos are coming! Unintended consequence from the torrent rains in California

University of California, Irvine — Tue, 18 Apr 2023 13:45:23 EST

Hidden 'super spreaders' spur dengue fever transmission

Emory University — Thu, 23 Mar 2023 16:25:32 EST

For mosquito-borne diseases such as dengue fever, the abundance of the insects in places where people gather has long served as the main barometer for infection risk. A new study, however, suggests that the number of "hidden" infections tied to a place, or cases of infected people who show no symptoms, is the key indicator for dengue risk.

Humans bite back by deactivating mosquito sperm

University of California, Riverside — Thu, 16 Mar 2023 14:40:19 EST

New UC Riverside research makes it likely that proteins responsible for activating mosquito sperm can be shut down, preventing them from swimming to or fertilizing eggs.

Small, convenient mosquito repellent device passes test to protect military personnel

University of Florida — Mon, 30 Jan 2023 08:30:59 EST

A device developed at the University of Florida for the U.S. military provides protection from mosquitos for an extended period and requires no heat, electricity or skin contact.

LJI Instructor Annie Elong Ngono, Ph.D., wins GVN support to advance infectious disease research

La Jolla Institute for Immunology — Mon, 12 Dec 2022 15:25:15 EST

LJI Instructor Annie Elong Ngono, Ph.D., has spearheaded important studies into the immune response to deadly pathogens such as dengue virus. Now, this dedication to global health and virology has earned her acceptance to the Global Virus Network's (GVN) highly selective Rising Star Mentorship Program.

To track disease-carrying mosquitoes, researchers tag them with DNA barcodes

Colorado State University — Tue, 29 Nov 2022 19:50:27 EST

West Nile, Zika, dengue and malaria are all diseases spread by bites from infected mosquitoes.

Preventing the next pandemic: Leaders of Pacific Rim Universities meet in Bangkok, Thailand

News — Mon, 14 Nov 2022 10:05:52 EST

Hosted by Chulalongkorn University the APRU APEC University Leaders' Forum 2022 is the first post-pandemic in-person APEC meeting held to foster high-level dialogue between CEOs, policy leaders, university presidents, and top researchers. This event begins Nov 15 at 9 PM EST.

Bobby Brooke Herrera Joins Rutgers Global Health Institute as Principal Faculty Member

Rutgers University-New Brunswick — Fri, 28 Oct 2022 14:45:43 EST

Research scientist Bobby Brooke Herrera, renowned for developing tools to accelerate diagnosis and treatment of infectious diseases such as COVID-19, has joined Rutgers Global Health Institute.

Global Virus Network (GVN) Adds Thailand's Mahidol University as Newest Member to Combat Viral Threats

Global Virus Network — Wed, 26 Oct 2022 12:20:07 EST

The Global Virus Network (GVN), representing 68 Centers of Excellence and 11 Affiliates in 39 countries comprising foremost experts in every class of virus causing disease in humans, and the Mahidol University in Thailand announced the addition of the Mahidol Virus Network as GVN's newest Center of Excellence.

New zika vaccine shows promise in animal models

American Society for Microbiology (ASM) — Wed, 28 Sep 2022 16:30:11 EST

Researchers from the University of California, Los Angeles (UCLA) have developed a Zika vaccine technology that is highly effective and safe in preclinical mouse models.

Medical Researcher Aims to Glimpse Inside the "Minds" of Viral Killers

Rutgers University-New Brunswick — Tue, 27 Sep 2022 10:05:31 EST

Ricardo Rajsbaum understands killers. Like a criminal investigator tracking prey, the Rutgers virologist spends his days researching the enemy. Rather than obsessing over a madman's next move, however, Rajsbaum's focus is on the microscopic viruses that infect human cells - sometimes with deadly consequences.

Chemical cocktail in skin summons disease-spreading mosquitoes

University of California, Riverside — Wed, 21 Sep 2022 13:45:25 EST

Mosquitoes that spread Zika, dengue and yellow fever are guided toward their victims by a scent from human skin. The exact composition of that scent has not been identified until now.

How human cells become Zika virus factories

La Jolla Institute for Immunology — Mon, 12 Sep 2022 13:05:12 EST

Scientists solve mystery of how Zika virus targets key immune cell. New finding shed light on how to stop virus from spreading.